Prometheus Biosciences Says Achieves Milestone Payment Of $10M From Dr. Falk Pharma GmbH
Prometheus Biosciences, Inc. (NASDAQ:RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion